...
首页> 外文期刊>Investigative ophthalmology & visual science >Tumor-infiltrating macrophages (CD68(+) cells) and prognosis in malignant uveal melanoma.
【24h】

Tumor-infiltrating macrophages (CD68(+) cells) and prognosis in malignant uveal melanoma.

机译:肿瘤浸润性巨噬细胞(CD68(+)细胞)和恶性葡萄膜黑色素瘤的预后。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: To investigate the hypothesis that tumor-infiltrating macrophages contribute to prognosis of uveal melanoma and to study their association with tumor characteristics, especially microvessels. METHODS: This was a retrospective, population-based cohort study of 167 consecutive patients who had had an eye with choroidal and ciliary body melanoma removed between 1972 and 1981. Macrophages were identified with mAb PG-M1 to the CD68 epitope, and their number and morphologic type were recorded. Kaplan-Meier and Cox regression analyses of melanoma-specific survival were performed. RESULTS: CD68-positive macrophages could be assessed in 139 (83%) of the 167 melanomas. Their number was moderate to high in 115 (83%) of the 139 tumors, and their morphology ranged from dendritic to round. A high number of macrophages was associated with presence of epithelioid cells (P = 0.025), heavy pigmentation (P = 0.001), and high microvascular density (P = 0.001). The 10-year melanoma-specific mortality rate increased with higher numbers of macrophages (0.10 for low versus 0.57 for high numbers, P = 0.0012). The morphologic type of infiltrating macrophages was not associated with mortality. The number of macrophages was modeled by stratification, which significantly improved a Cox regression model (P < 0.001). Adjusting for the other independent indicators of metastatic death 10-year melanoma-specific mortality was 0.17 for low versus 0.45 for high numbers of macrophages. CONCLUSIONS: The number of tumor-infiltrating CD68-positive macrophages contributes to prognosis and associates with cell type and microvascular density, which merits a further analysis of the biological role of these cells in uveal melanoma.
机译:目的:探讨肿瘤浸润性巨噬细胞有助于葡萄膜黑色素瘤预后的假说,并研究其与肿瘤特征,尤其是微血管的关系。方法:这是一项基于人群的回顾性队列研究,研究对象是1972年至1981年间连续167例脉络膜和睫状体黑色素瘤摘除的患者。巨噬细胞由CD68表位的mAb PG-M1鉴定,其数量和记录形态学类型。进行了黑素瘤特异性生存的Kaplan-Meier和Cox回归分析。结果:167例黑色素瘤中有139例(83%)可评估CD68阳性巨噬细胞。在139例肿瘤中,有115例(占83%)的肿瘤数量中等至高,且形态从树突状到圆形不等。大量巨噬细胞与上皮样细胞的存在(P = 0.025),色素沉着(P = 0.001)和高微血管密度(P = 0.001)有关。 10年黑素瘤特异性死亡率随着巨噬细胞数量的增加而增加(低数为0.10,高数为0.57,P = 0.0012)。浸润性巨噬细胞的形态学类型与死亡率无关。通过分层对巨噬细胞的数量进行建模,这显着改善了Cox回归模型(P <0.001)。调整其他独立的转移性死亡指标,十年期黑色素瘤特异性死亡率低(0.17%),高巨噬细胞(0.45%)。结论:肿瘤浸润性CD68阳性巨噬细胞的数量有助于预后,并与细胞类型和微血管密度有关,这需要进一步分析这些细胞在葡萄膜黑色素瘤中的生物学作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号